Clinical Takeaway Scare-tactic cannabis prevention campaigns often fail because teens hold widely different beliefs about the drug, and a one-size-fits-all message rarely lands. This research tested a smarter approach: when a teen...
`Endocannabinoid System Research: Cannabis in HIV Care`
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed strong feasibility and acceptability as a smoking cessation tool, suggesting this population can be effectively reached through app-based interventions....
Cannabinoid Clinical Trials: Cannabis Intervention in Teens
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and refutes adolescents’ negative reactions to anti-cannabis appeals, then delivers a third targeted communication, shows promise as a more effective approach than one-size-fits-all...
Endocannabinoid System Research: Cannabis & HIV Smoking
Clinical Takeaway Digital therapeutics tailored to people living with HIV show promising feasibility and acceptability as a scalable approach to smoking cessation in this high-risk population. Tobacco use remains a leading driver...
Cannabinoid Clinical Trials: Teen Cannabis Intervention Study
Clinical Takeaway Research suggests that standard cannabis prevention messaging often fails teens because it does not account for the wide range of beliefs young people hold about cannabis use. This study tested...
`Cannabinoid Clinical Trials: Digital Smoking Cessation HIV`
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed strong feasibility and acceptability as a smoking cessation tool in this pilot trial, suggesting this population can be reached...